These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 26206443)
21. Frequency of electrocardiogram testing among HIV-infected patients at risk for medication-induced QTc prolongation. Patel N; Veve M; Kwon S; McNutt LA; Fish D; Miller CD HIV Med; 2013 Sep; 14(8):463-71. PubMed ID: 23506263 [TBL] [Abstract][Full Text] [Related]
22. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes? Samuelov-Kinori L; Kinori M; Kogan Y; Swartzon M; Shalev H; Guy D; Ferenidou F; Mashav N; Sadeh B; Atzmony L; Kliuk-Ben-Basat O; Steinvil A; Justo D J Electrocardiol; 2009; 42(4):353-357.e1. PubMed ID: 19261294 [TBL] [Abstract][Full Text] [Related]
24. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome. Ackerman MJ; Khositseth A; Tester DJ; Hejlik JB; Shen WK; Porter CB Mayo Clin Proc; 2002 May; 77(5):413-21. PubMed ID: 12004990 [TBL] [Abstract][Full Text] [Related]
25. The QT and corrected QT interval in recovery after exercise in children. Berger WR; Gow RM; Kamberi S; Cheung M; Smith KR; Davis AM Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):448-55. PubMed ID: 21606386 [TBL] [Abstract][Full Text] [Related]
26. Validation of a population-based method to assess drug-induced alterations in the QT interval: a self-controlled crossover study. Iribarren C; Round AD; Peng JA; Lu M; Zaroff JG; Holve TJ; Prasad A; Stang P Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1222-32. PubMed ID: 23857878 [TBL] [Abstract][Full Text] [Related]
27. Return to play? Athletes with congenital long QT syndrome. Johnson JN; Ackerman MJ Br J Sports Med; 2013 Jan; 47(1):28-33. PubMed ID: 23193325 [TBL] [Abstract][Full Text] [Related]
28. The prevalence and significance of a short QT interval in 18,825 low-risk individuals including athletes. Dhutia H; Malhotra A; Parpia S; Gabus V; Finocchiaro G; Mellor G; Merghani A; Millar L; Narain R; Sheikh N; Behr ER; Papadakis M; Sharma S Br J Sports Med; 2016 Jan; 50(2):124-9. PubMed ID: 26400956 [TBL] [Abstract][Full Text] [Related]
29. Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patients. Nordin C; Kohli A; Beca S; Zaharia V; Grant T; Leider J; Marantz P J Electrocardiol; 2006 Apr; 39(2):199-205. PubMed ID: 16580420 [TBL] [Abstract][Full Text] [Related]
30. Frequency and prognostic significance of QT prolongation in chronic renal failure patients. Voiculescu M; Ionescu C; Ismail G Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617 [TBL] [Abstract][Full Text] [Related]
31. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation. Milic M; Bao X; Rizos D; Liu F; Ziegler MG Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469 [TBL] [Abstract][Full Text] [Related]
32. Prescription of drugs with potential adverse effects on cardiac conduction in Parkinson's disease. Malek NM; Grosset KA; Stewart D; Macphee GJ; Grosset DG Parkinsonism Relat Disord; 2013 Jun; 19(6):586-9. PubMed ID: 23522959 [TBL] [Abstract][Full Text] [Related]
33. Prevalence and Risk Factors of Drug-Associated Corrected QT Prolongation in Elderly Hospitalized Patients: Results of a Retrospective Analysis of Data Obtained Over 6 Months. Maison O; de la Gastine B; Dayot L; Goutelle S Drugs Aging; 2017 Jul; 34(7):545-553. PubMed ID: 28577045 [TBL] [Abstract][Full Text] [Related]
34. QTc interval prolongation in HIV-negative versus HIV-positive subjects with or without antiretroviral drugs. Ogunmola OJ; Oladosu YO; Olamoyegun MA Ann Afr Med; 2015; 14(4):169-76. PubMed ID: 26470741 [TBL] [Abstract][Full Text] [Related]
35. Effect of age and overweight on the QT interval and the prevalence of long QT syndrome in children. Fukushige T; Yoshinaga M; Shimago A; Nishi J; Kono Y; Nomura Y; Miyata K; Imamura M; Shibata T; Nagashima M; Niimura I Am J Cardiol; 2002 Feb; 89(4):395-8. PubMed ID: 11835918 [TBL] [Abstract][Full Text] [Related]
36. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444 [TBL] [Abstract][Full Text] [Related]
38. Changes in QT interval with exercise in elite male rowers and controls. Rajappan K; O'Connell C; Sheridan DJ Int J Cardiol; 2003 Feb; 87(2-3):217-22. PubMed ID: 12559542 [TBL] [Abstract][Full Text] [Related]